Molecular & Cellular Characterisation of Oral Lichen Planus

Overview

The principal research objective is to provide enhanced understanding of the cellular and molecular events important in the pathogenesis of Oral Lichen Planus to enable improved diagnosis and development of novel treatments for patients.

Full Title of Study: “Molecular & Cellular Characterisation of Oral Lichen Planus”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: February 26, 2023

Detailed Description

The following questions will also be addressed: 1. Are the histological architectural tissue changes that take place in oral lichen planus quantifiable using computer based imaging, graph theory and fractal geometry principles? Quantification of these changes would allow the development of a tool to facilitate the accurate measurement of response to treatment. 2. What is the nature of such architectural changes and what are the differences with normal, dysplastic and neoplastic epithelia (the investigators have morphometrical data collected from previous research to allow such comparisons). 3. Is it possible to produce evidence-based statistical classification into established diagnostic classes using the proposed methodology? This would contribute towards making histopathological diagnosis more quantitative, reproducible and accurate. 4. Is it possible to automate such morphometrical analysis/classification? This would allow large data sets to be screened automatically in a shorter time frame and at lower cost than human based screening. 5. Is it possible to determine differences in genetics and gene expression of keratinocytes involved in Oral Lichen Planus compared to those of 'normal' tissue by using biopsy material and an in vitro model of oral lichen planus?

Clinical Trial Outcome Measures

Primary Measures

  • Histological architecture
    • Time Frame: Through study completion, (maximum 12 months from the defined end of study)
    • Are the histological architectural tissue changes that take place in oral lichen planus quantifiable using computer based imaging, graph theory and fractal geometry principles?
  • Comparisons with other dysplastic lesions
    • Time Frame: Through study completion, (maximum 12 months from the defined end of study)
    • What is the nature of such architectural changes and what are the differences with normal, dysplastic and neoplastic epithelia
  • Statistical classifications
    • Time Frame: Through study completion, (maximum 12 months from the defined end of study)
    • Is it possible to produce evidence-based statistical classification into established diagnostic classes using the proposed methodology
  • Automation of morphological features
    • Time Frame: Through study completion, (maximum 12 months from the defined end of study)
    • Is it possible to automate such morphometrical analysis/classification?
  • Molecular expression of Oral Lichen Planus markers
    • Time Frame: Through study completion, (maximum 12 months from the defined end of study)
    • Is it possible to determine differences in genetics and gene expression of keratinocytes involved in Oral Lichen Planus compared to those of ‘normal’ tissue by using biopsy material and an in vitro model of oral lichen planus?

Participating in This Clinical Trial

Inclusion Criteria

1. Patient is 16 years old or over 2. Patient is willing and able to provide valid informed consent 3. Patient is attending the Oral Lichen Planus clinic and will be having a routine clinical biopsy taken Exclusion Criteria:

1. Patient under 16 years old 2. Patient is immunocompromised 3. Patients with comorbid disease state e.g. other inflammatory disease

Gender Eligibility: All

Minimum Age: 16 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Birmingham
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Gabriel Landini, Phd, +44 0121 466 5519, G.Landini@bham.ac.uk

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.